Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Orkambi (lumacaftor/ivacaftor) Covered by Aetna CVS Health in Ohio: Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Orkambi Covered by Aetna CVS Health in Ohio Orkambi (lumacaftor/ivacaftor) requires prior authorization from Aetna CVS Health for cystic fibrosis patients who are homozygous for the F508del mutation. The fastest path to approval: (1) Confirm genetic testing shows F508del homozygous status, (2) Have a pulmonologist submit

How to Get Aldurazyme (Laronidase) Covered by Aetna CVS Health in Virginia: Complete Guide with Forms and Appeal Scripts

Answer Box: Quick Path to Approval Aldurazyme (laronidase) is covered by Aetna CVS Health but requires prior authorization with genetic/enzyme confirmation of MPS I diagnosis. Here's your fastest path: 1. Gather documentation: Genetic test results (IDUA gene mutation) or enzyme assay, baseline clinical assessments, and complete medical

How to Get Tecentriq (atezolizumab) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide

Quick Answer: Getting Tecentriq Covered by Aetna CVS Health in Florida Tecentriq (atezolizumab) requires prior authorization from Aetna CVS Health for all FDA-approved cancer indications. Your fastest path to approval: (1) Ensure your diagnosis matches an FDA-labeled indication with required biomarker testing (PD-L1 ≥1% for NSCLC adjuvant, ≥50% for first-line

Renewing Firazyr (Icatibant) Approval with Aetna CVS Health in Ohio: Complete Timeline & Forms Guide

Answer Box: Renewing Firazyr (Icatibant) with Aetna CVS Health in Ohio Start your renewal 60-90 days before your current authorization expires. Aetna requires their Firazyr-Sajazir Injection Medication Precertification Request form with updated clinical documentation showing ongoing HAE attacks and treatment response. Submit via Aetna provider portal (3-5 business days) or

How to Get Ocrevus (Ocrelizumab) Covered by Aetna CVS Health in Illinois: Timeline, Forms & Appeals

Answer Box: Get Ocrevus Covered by Aetna CVS Health in Illinois Aetna requires prior authorization for Ocrevus (ocrelizumab), which typically takes 24-72 hours for standard review. Your neurologist must submit the precertification through Aetna's Availity portal or by calling 1-866-752-7021. If denied, Illinois residents have 180 days for

How to Get Rezlidhia (Olutasidenib) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Rezlidhia (Olutasidenib) Covered by Aetna CVS Health in Illinois Rezlidhia (olutasidenib) requires prior authorization from Aetna CVS Health. Your hematologist/oncologist must document IDH1 mutation, relapsed/refractory AML diagnosis, and prior treatment failures. If denied, you have 180 days to appeal internally, then 4 months for Illinois

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Aetna CVS Health in Pennsylvania: Complete Guide with Forms and Appeal Process

Quick Answer: Getting Besponsa Covered in Pennsylvania Besponsa (inotuzumab ozogamicin) requires prior authorization from Aetna CVS Health for CD22-positive B-cell ALL. In Pennsylvania, you have strong appeal rights—about 50% of external reviews overturn denials. Start today: 1) Verify your plan covers specialty drugs, 2) Have your oncologist submit the

How to Get Adynovate (Antihemophilic Factor) Covered by Aetna CVS Health in Virginia: Copay Cards, Prior Authorization, and Appeals Process

Answer Box: Getting Adynovate Covered by Aetna CVS Health in Virginia Fastest Path to Approval: Most Aetna CVS Health plans require prior authorization for Adynovate (antihemophilic factor, PEGylated). Your hematologist submits clinical documentation showing hemophilia A diagnosis, bleeding history, and medical necessity for extended half-life factor VIII. If denied, Virginia&

How to Get Kymriah (Tisagenlecleucel) Covered by Aetna CVS Health in Michigan: Complete Guide to Approval, Appeals, and Cost-Saving Options

Answer Box: Getting Kymriah Covered by Aetna CVS Health in Michigan Aetna CVS Health covers Kymriah (tisagenlecleucel) for FDA-approved indications with prior authorization. For B-cell ALL patients under 26 or adults with relapsed/refractory DLBCL, treatment must occur at a certified center in Aetna's network. Start by having

How to Get Strensiq (Asfotase Alfa) Covered by Aetna in Michigan: Complete Guide to Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Strensiq Covered by Aetna in Michigan Fastest path to approval: Aetna requires prior authorization for Strensiq (asfotase alfa) with strict clinical criteria. You need documented perinatal/infantile or juvenile-onset hypophosphatasia, genetic testing or biochemical confirmation, and proof the condition started before age 18. First step today: Contact